Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Mukai, K.
Right arrow Articles by Shimosato, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mukai, K.
Right arrow Articles by Shimosato, Y.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Japanese Journal of Clinical Oncology 18:195-201 (1988)
© 1988 Foundation for Promotion of Cancer Research


research-article

The Incidence of Secondary Tumors of the Heart and Pericardium: A 10-Year Study

Kiyoshi Mukai, M.D*,1, Tetsu Shinkai, M.D2, Keigo Tominaga, M.D2,3 and Yukio Shimosato, M.D1

1Pathology Division, National Cancer Center Research Institute 1-1, Tsukiji 5-chome, Chuo-ku, Tokyo 104
2Internal Medicine, National Cancer Center Hospital 1-1, Tsukiji 5-chome, Chuo-ku, Tokyo 104

* For reprints and all correspondence

Received December 25, 1987; accepted March 10, 1988

Secondary tumors of the heart and pericardium are much more common than primary tumors. During a 10-year period (1976–1985), only one instance of a primary tumor (malignant mesothelioma) was identified among 2,649 autopsies of malignant tumors at the National Cancer Center Hospital. In contrast, there were 407 cases in which heart and/or pericardium were secondarily involved with a malignant tumor from other organs. In 78 cases, the secondary tumors were present only in the pericardium, while in 329 cases, the tumors involved the heart itself with or without pericardial involvement. Among the primary tumors, three-quarters were carcinomas of various organs. In addition there were 53 hematologic malignancies, 19 melanomas and 17 sarcomas. In 31 cases, cardiac failure was the direct cause of death. The secondary tumors of the heart were often overlooked clinically because the cardiac dysfunction appeared to be part of the deteriorating general condition. Electrocardiography and echocardiography were often helpful in suggesting the presence of cardiac metastases. Appropriate diagnostic procedures and therapeutic intervention should be considered for the care of patients with advanced malignancy and sudden onset of cardiac failure.

Key Words: Heart • Pericardium • Metastatic tumors • Electrocardiography • Echocardiography

3Current address: Internal Medicine, Tochigi Cancer Center, Utsunomiya.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Eur J EchocardiogrHome page
N. Samiei, M. M. Farahani, A. Sadeghipour, K. Mozaffari, and M. Maleki
Intracardiac metastasis of malignant melanoma
Eur J Echocardiogr, May 1, 2008; 9(3): 393 - 394.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
S. G. Spiro, M. K. Gould, and G. L. Colice
Initial Evaluation of the Patient With Lung Cancer: Symptoms, Signs, Laboratory Tests, and Paraneoplastic Syndromes: ACCP Evidenced-Based Clinical Practice Guidelines (2nd Edition)
Chest, September 1, 2007; 132(3_suppl): 149S - 160S.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Radiol.Home page
A D Borsaru, K K Lau, and P Solin
Cardiac metastasis: a cause of recurrent pulmonary emboli
Br. J. Radiol., February 1, 2007; 80(950): e50 - e53.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
R Bussani, F De-Giorgio, A Abbate, and F Silvestri
Cardiac metastases
J. Clin. Pathol., January 1, 2007; 60(1): 27 - 34.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
M. A. Beckles, S. G. Spiro, G. L. Colice, and R. M. Rudd
Initial Evaluation of the Patient With Lung Cancer: Symptoms, Signs, Laboratory Tests, and Paraneoplastic Syndromes
Chest, January 1, 2003; 123 (2009): 97S - 104S.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
B. Maisch, A.D. Ristic, S. Pankuweit, A. Neubauer, and R. Moll
Neoplastic pericardial effusion. Efficacy and safety of intrapericardial treatment with cisplatin
Eur. Heart J., October 2, 2002; 23(20): 1625 - 1631.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
Y. Kudo, F. Yamasaki, Y. Doi, and T. Sugiura
clinical correlates of pr-segment depression in asymptomatic patients with pericardial effusion
J. Am. Coll. Cardiol., June 19, 2002; 39(12): 2000 - 2004.
[Abstract] [Full Text] [PDF]


Home page
RadioGraphicsHome page
C. Chiles, P. K. Woodard, F. R. Gutierrez, and K. M. Link
Metastatic Involvement of the Heart and Pericardium: CT and MR Imaging
RadioGraphics, March 1, 2001; 21(2): 439 - 449.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
P.-C. Wang, K.-Y. Yang, J.-Y. Chao, J. M. Liu, R.-P. Perng, and S.-H. Yen
Prognostic Role of Pericardial Fluid Cytology in Cardiac Tamponade Associated With Non-small Cell Lung Cancer
Chest, September 1, 2000; 118(3): 744 - 749.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
E. Barasch, R. Hariharan, P. F. Wong, and K. A. Heck
Pleural and Pericardial Effusions in a 50-Year-Old Woman
Circulation, June 15, 1996; 93(12): 2197 - 2202.
[Full Text]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.